Neutrophil‐to‐lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients-Reference-Cited by-同舟云学术

Neutrophil‐to‐lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients

Published:2014-02-12 Issue:2 Volume:3 Page:406-415
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Xue Peng¹²,Kanai Masashi¹,Mori Yukiko³,Nishimura Takafumi³,Uza Norimitsu⁴,Kodama Yuzo⁴,Kawaguchi Yoshiya⁵,Takaori Kyoichi⁵,Matsumoto Shigemi¹,Uemoto Shinji⁵,Chiba Tsutomu⁴

Affiliation:

1. Department of Clinical Oncology and Pharmacogenomics Kyoto University Graduate School of Medicine Kyoto Japan

2. Department of Medical Oncology and Shanghai Key Laboratory for Pancreatic Diseases Shanghai First People's Hospital Shanghai Jiaotong University Shanghai China

3. Department of Translational Clinical Oncology Kyoto University Graduate School of Medicine Kyoto Japan

4. Department of Gastroenterology and Hepatology Kyoto University Graduate School of Medicine Kyoto Japan

5. Department of Surgery Kyoto University Graduate School of Medicine Kyoto Japan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.204

Reference30 articles.

1. Cancer statistics, 2013

2. Advanced pancreatic carcinoma: current treatment and future challenges